April 21, 2026
According to market projections, the global oncology API market, valued at USD 41.79 billion in 2024, is anticipated to reach USD 69.55 billion by 2034, growing at a CAGR of 5.24% over the next decade. The rising prevalence of cancer and the growing ...
April 21, 2026
According to market projections, the oncology drugs sector is expected to grow from USD 204.39 billion in 2024 to USD 360.79 billion by 2034, reflecting a CAGR of 6.29%. The oncology drugs market is growing due to the increasing incidence of cancer, ...
April 21, 2026
The oncology biomarker market is valued at USD 38.62 billion in 2025 and is projected to reach USD 113.54 billion by 2034, growing at a CAGR of 12.73%. The report covers market segments by biomarker type, including genomic (35% share in 2024) and pro...
April 16, 2026
Orphan Oncology Market (By Therapy Type: Monoclonal Antibodies, Targeted Therapy, Immunotherapy, Chemotherapy, Cancer Vaccines; By Application: Oncology Treatment, Healthcare, Pharmaceuticals, Research, Clinical Trials; By Drug Modality: Biologi...
April 21, 2026
The global Pre-Dx oncology market is growing with rising cancer incidence and advanced early detection technologies. North America led with 45% share in 2024, while Asia Pacific is fastest-growing. Liquid biopsy tests accounted for 40% revenue, MCED ...
April 21, 2026
According to market projections, the radiation oncology sector is expected to grow from USD 12.45 billion in 2025 to USD 36.78 billion by 2035, reflecting a CAGR of 11.44%. The rising prevalence of cancer and technological advancements drive the glob...
April 21, 2026
Market insights predict the APAC clinical trials industry will increase from USD 18.87 billion in 2025 to USD 41.33 billion by 2035, achieving a CAGR of 7.16%. The market is growing due to the increasing demand for new and effective therapies and ris...
April 21, 2026
Projections indicate that, GMP peptides industry is projected to rise from USD 1.3 billion in 2024 to USD 2.9 billion by 2034, reflecting a CAGR of 8.35% over the next decade. The growing demand for peptide drugs and technological advancements drives...
February 19, 2026
According to market projections, the Europe pharmaceutical market, valued at USD 467.59 billion in 2024, is anticipated to reach USD 820.05 billion by 2034, growing at a CAGR of 5.78% over the next decade. The Europe pharmaceutical market is expandin...
April 21, 2026
Based on market forecasts, the U.S. oncology sector will expand from USD 72.79 billion in 2024 to USD 211.78 billion by 2034, experiencing a CAGR of 11.75%. The West region led the market due to the vital contribution of California in the oncology ...
April 10, 2026
Personalized Cancer Vaccine Market (By Vaccine Type: Neoantigen-Based Vaccines, Dendritic Cell Vaccines, Tumor Cell Vaccines, Viral Vector-Based Vaccines; By Cancer Type: Melanoma, Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Other...
April 24, 2026
Brain Cancer Market (By Product/Solution Type: Therapeutic Treatments, Diagnostic Imaging, Surgical Devices, Supportive Care Products; By Treatment Modality: Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgery, Tumor Treating Fi...
April 21, 2026
According to market projections, the oncology drug discovery sector is growing due to the rising prevalence of cancer and increasing demand for targeted, personalized therapies. Advances in genomics and biotechnology are accelerating the development ...
April 02, 2026
AI In Oncology Market ( By Component: Software Solutions, Hardware, Services; By Application: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer Brain Tumors, Others; By End-User: Hospitals, Pharmaceutical Companies, Research Institutes, ...
January 06, 2026
Based on market forecasts, the bRo5 molecules market is witnessing rapid expansion due to increasing pharmaceutical R&D investments, growing adoption of AI-assisted drug discovery platforms, and rising oncology and CNS disorder prevalence. The ma...
April 21, 2026
Forecasts suggest that the non-oncology precision medicine market will expand from USD 83.87 billion in 2024 to USD 193.16 billion by 2034, with a CAGR of 8.7% during this period. Non-Oncology Precision Medicine tailors treatments to individual patie...
February 25, 2026
The United States AI in Oncology market was valued at USD 720.04 million in 2025 and is projected to grow from USD 921.29 million in 2026 to USD 8,467.58 million by 2035, expanding at a strong CAGR of 27.95% during 2026–2035...
April 21, 2026
The veterinary oncology market reached USD 1.58 billion in 2024 and is set to grow to USD 1.77 billion in 2025, reaching USD 4.86 billion by 2034 at a CAGR of 12.14%. The report covers market segmentation by animal, therapy, and cancer type, regional...
January 16, 2026
Market insights predict, the targeted therapy industry is expected to grow from USD 85.69 billion in 2025 to USD 166.53 billion by 2035, driven by a CAGR of 6.87%. In 2024, North America led the targeted therapy market (32%), with Asia Pacific set fo...
April 21, 2026
Based on market forecasts, the U.S. oncology molecular diagnostics sector will expand from USD 810 million in 2024 to USD 2570.17 million by 2034, experiencing a CAGR of 12.24%. In 2024, breast cancer dominated the market, while liver cancer is expec...
April 21, 2026
The advanced liver cancer treatment drugs market is expanding due to increased adoption of systemic therapies over traditional chemotherapy and growing approvals of immuno-oncology agents. North America led the market due to the presence of a well-de...
April 21, 2026
Market insights predict, the oncology automation industry is expected to grow from USD 2.82 billion in 2024 to USD 7.77 billion by 2034, driven by a CAGR of 10.68%. The oncology automation market is growing due to rising cases of cancer, leading to a...
January 19, 2026
According to market projections, the oncology NGS sector is expected to grow from USD 589.01 million in 2025 to USD 2538.52 million by 2035, reflecting a CAGR of 15.73%. The demand for NGS in oncology is high due to growing cases of cancer and R&...
April 21, 2026
Market insights predict the global clinical trial imaging industry will increase from USD 2.41 billion in 2024 to USD 5.58 billion by 2034, achieving a CAGR of 8.8%. The market is growing due to the increasing adoption of advanced imaging technologie...
May 04, 2026
Precision Oncology Market (By Product: Therapeutics, Diagnostics; By Cancer Type: Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer, Blood Cancer, Prostate Cancer, Others; By End-Use: Pharmaceutical & Biotechnology Companies, Hospita...
January 13, 2026
Market insights predict the global hemato-oncology testing industry will increase from USD 4 billion in 2025 to USD 12.88 billion by 2035, achieving a CAGR of 12.4%. In 2023, service offerings led the market with a 58% share. Leukemia remained the to...
January 12, 2026
Projections indicate that, surgical microscope industry is projected to rise from USD 1.52 billion in 2025 to USD 4.31 billion by 2035, reflecting a CAGR of 10.97% over the next decade.Investments in healthcare infrastructure, especially in emergin...
March 18, 2026
According to market projections, the oncology devices sector is expected to grow from USD 177.17 billion in 2025 to USD 914.79 billion by 2035, reflecting a CAGR of 17.84%. The increasing prevalence and awareness of cancer and the shift towards perso...
April 21, 2026
According to market projections, the U.S. oncology drugs sector is expected to grow from USD 95.69 billion in 2024 to USD 246.85 billion by 2034, reflecting a CAGR of 9.94%. The extensive research, scientific innovations, and the market penetration...
April 14, 2026
Brain Tumor Drugs Market (By Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, Others; By Indication: Pituitary, Meningioma, Glioma, Others; By Distribution Channel: Hospital Pharmacy, Retail & Online Pharmacy, By Region: North America, Asi...
April 21, 2026
The multiple modalities in oncology market is expanding due to increasing tumor heterogeneity as well as growing treatment approaches. North America led the market due to the presence of the advanced healthcare sector....
April 21, 2026
The microfluidics in oncology market is growing due to this system offering more sensitive and precise detection of cancer biomarkers and therapeutic approaches than traditional assays....
April 08, 2026
Oncology Molecular Diagnostics Market ( By Type: Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer Others; By Product: Instruments, Reagents, Others; By Technology: PCR, In-situ...
April 21, 2026
Based on market forecasts, the global oncology market, projected at USD 225.05 billion in 2024, is expected to reach USD 748.17 billion by 2035, growing at a CAGR of 11.54% over the forecast period.The oncology market is expanding due to rising can...
May 04, 2026
Oncology Companion Diagnostic Market (By Product & Services: Product, Software; By Technology: Polymerase Chain Reaction, Next-generation Sequencing, Immunohistochemistry, In Situ Hybridization (ISH)/Fluorescence In Situ Hybridization, Other Tech...
April 21, 2026
The rising prevalence of cancer and technological advancements are the major growth factors of the market. North America dominated the global market, owing to favorable government initiatives and increasing investments....
February 05, 2026
According to market projections, the oncology clinical trial sector is expected to grow from USD 14.36 billion in 2025 to USD 24.07 billion by 2035, reflecting a CAGR of 5.3%. Growing patient awareness, better diagnostic tools have increased the dema...
April 21, 2026
Market insights predict, the investigational new drug CDMO industry is expected to grow from USD 5.66 billion in 2025 to USD 11.10 billion by 2035, driven by a CAGR of 6.97%. The investigational new drug CDMO market is expanding due to increasing dev...
April 21, 2026
Rising advantages of AI and ML in the world are reducing timelines, cost-effective approaches in drug discovery and clinical trials are driving the global market. North America was dominant in the market due to technological advancements by using AI ...
April 24, 2026
Multispecific Antibodies (By Therapy Type: Bispecific Antibodies, Trispecific Antibodies, Other Multispecific Antibodies; By Application: Oncology, Autoimmune Diseases, Infectious Diseases, Other Therapeutic Areas; By Drug Class: Monoclonal Antibodie...
April 21, 2026
The rapid genomic diagnostics market is rising due to the growing focus on rare disease & genetic disease diagnostics. North America’s dominance is attributed to technological advancements in bioinformatics....
April 21, 2026
Based on market forecasts, the global tele-oncology market, projected at USD 4.74 billion in 2024, is expected to reach USD 20.48 billion by 2034, growing at a CAGR of 15.76% over the forecast period. A sure sign of the adoption of advanced he...
April 21, 2026
Market insights predict the global radionuclide drug conjugates (RDC) industry will increase from USD 3.24 billion in 2024 to USD 8.87 billion by 2034, achieving a CAGR of 10.54%. The global radionuclide drug conjugates (RDC) market is growing stro...
April 21, 2026
Based on market forecasts, the monoclonal antibodies therapeutics sector will expand from USD 265.17 billion in 2024 to USD 1057.91 billion by 2034, experiencing a CAGR of 14.84%. In 2024, North America led the monoclonal antibody therapeutics market...
February 17, 2026
Our projections indicate that, the oncology clinical trial monitor market was valued at USD 15.76 billion in 2026 and is projected to reach USD 25.6 billion by 2035, expanding at a CAGR of 5.54% (2026–2035)....
May 04, 2026
Metastatic Breast Cancer Market (By Therapy Type: Chemotherapy, Hormonal Therapy, Targeted Therapy, Immunotherapy; By Cancer Subtype: Hormone Receptor Positive (HR+) / HER2 Negative, HER2 Positive, Triple-Negative Breast Cancer (TNBC); By Route of Ad...
April 21, 2026
Based on market forecasts, the global radiotherapy market, projected at USD 7.88 billion in 2024, is expected to reach USD 15.63 billion by 2034, growing at a CAGR of 7.09% over the forecast period. The market is expanding due to the increasing glo...
April 21, 2026
The U.S. oncology pharmaceutical market is expanding due to increasing cancer awareness as well as growing cancer drug development. ...
February 27, 2026
According to our projections, the AI in oncology for analytical solutions market was valued at USD 1.62 billion in 2025 and is projected to reach USD 2.19 billion in 2026, further expanding to USD 33.87 billion by 2035, registering a robust CAGR of 3...
April 21, 2026
According to market projections, the immuno-oncology drugs sector is expected to grow from USD 94 billion in 2024 to USD 421.27 billion by 2034, reflecting a CAGR of 16.34%. Across the globe, a rising number of cancer patients is associated with the ...
April 21, 2026
Market insights predict, the oncology biosimilars industry is expected to grow from USD 6.7 billion in 2024 to USD 36.23 billion by 2034, driven by a CAGR of 18.47%. The oncology biosimilars market is witnessing rapid growth, offering similar and c...
April 21, 2026
According to market projections, the global biopharmaceutical contract manufacturing market, valued at USD 40.14 billion in 2024, is anticipated to reach USD 115.65 billion by 2034, growing at a CAGR of 11.14% over the next decade.The biopharmaceut...
April 21, 2026
The insulin API market report presents a complete segmentation and trade analysis covering human insulin, analog insulin, and biosimilar APIs. It provides regional data for NA, EU, APAC, LA, and MEA, highlighting production volumes, demand patterns, ...
April 21, 2026
According to forecasts, the global berberine API market will grow from USD 523 million in 2024 to USD 973.13 million by 2034, with an expected CAGR of 6.45%.The berberine API market is growing due to its wide use in nutraceuticals, pharmaceuticals, a...
April 21, 2026
According to market projections, the steroid hormone API sector is expected to grow from USD 3.54 billion in 2024 to USD 6.06 billion by 2034, reflecting a CAGR of 5.54%. The steroid hormone API market is growing due to rising demand for natural ster...
February 04, 2026
According to our projections, the chlorogenic acid API market was valued at USD 150 million in 2025 and is projected to grow from USD 154.58 million in 2026 to USD 202.57 million by 2035, registering a CAGR of 3.05% during the forecast period....
April 21, 2026
According to market projections, the small molecule API sector is expected to grow from USD 206.9 billion in 2025 to USD 374.03 billion by 2035, reflecting a CAGR of 6.1%. The small molecule API market is growing due to rising investment by key playe...
April 21, 2026
According to market projections, the serum gonadotrophin API sector is expected to grow from USD 131 million in 2024 to USD 202.93 million by 2034, reflecting a CAGR of 4.64%. The market is growing due to rising demand for fertility treatment and ass...
January 19, 2026
Our projections indicate that, respiratory API industry is projected to rise from USD 20.78 billion in 2025 to USD 39.9 billion by 2035, reflecting a CAGR of 6.74% over the next decade. The rising prevalence of respiratory disorders, combined with gr...
March 09, 2026
Our projections indicate that, the small molecule innovator API CDMO market was valued at USD 27.6 billion in 2025 and is projected to reach USD 28.46 billion in 2026, expanding to USD 50.54 billion by 2035 at a CAGR of 6.59% during 2026–2035....
February 16, 2026
According to our projections, the API stability testing services market was valued at USD 1.48 billion in 2025 and is projected to reach USD 1.55 billion in 2026, further expanding to USD 2.35 billion by 2035 at a CAGR of 4.74% (2026–2035)....
February 23, 2026
Based on our estimations, the U.S. small molecule innovator API CDMO market was valued at USD 9.37 billion in 2025 and reached USD 9.94 billion in 2026, and is projected to grow to USD 16.85 billion by 2035, expanding at a CAGR of 6.04% from 2026 to ...
April 21, 2026
According to market projections, the global non-ionic contrast media API market, valued at USD 1.81 billion in 2024, is anticipated to reach USD 3.32 billion by 2034, growing at a CAGR of 6.34% over the next decade.The non-ionic contrast media API ma...
April 21, 2026
According to market estimations, the clavulanic acid series API market, valued at US$ 385 million in 2023, is projected to reach US$ 777.66 million by 2034, driven by rising antibiotic resistance and R&D. North America leads, Asia-Pacific grows...
April 21, 2026
According to market projections, the teleradiology sector is expected to grow from USD 10.16 billion in 2025 to USD 38.43 billion by 2035, reflecting a CAGR of 14.23%. The significant need for radiology services is due to a shortage of the workforce ...
April 21, 2026
Market insights predict, the cartilage repair industry is expected to grow from USD 1.51 billion in 2024 to USD 7.32 billion by 2034, driven by a CAGR of 17.14%. The cartilage repair market is growing due to the rising geriatric population. Nor...
March 31, 2026
Cancer Biomarkers Market (By Type: Breast cancer, Prostate cancer, Colorectal cancer, Cervical cancer, Liver cancer, Lung cancer, Others; By Biomolecule: Genetic Biomarkers, Epigenetic Biomarkers, Metabolic Biomarkers, Proteomic Biomarkers, Others; B...
February 10, 2026
Based on our forecasts, the iPSC cell therapies market was valued at USD 10.44 billion in 2025 and is expected to reach USD 11.64 billion by 2026, growing steadily to approximately USD 30.87 billion by 2035 at a CAGR of 11.45% during the forecast per...
April 21, 2026
Market insights predict the U.S. pharmaceutical industry will increase from USD 520.4 billion in 2025 to USD 965 billion by 2035, achieving a CAGR of 6.37%. The strong presence of pharmaceutical companies and favorable regulatory support bolsters mar...
April 21, 2026
The HIV PrEP market is expanding due to its growing approvals as well as rising long-acting injectable PrEP innovations. North America led the market due to the early adoption of the HIV PrEP....
March 13, 2026
Projections indicate that, the global healthcare biometrics market will increase from USD 9.86 billion in 2025 to USD 48.77 billion by 2035, experiencing a CAGR of 17.34% over the next 10 years. The market is expanding due to rising concerns over t...
April 21, 2026
According to market projections, the global respiratory disease vaccine market, valued at USD 65.72 billion in 2025, is anticipated to reach USD 98.41 billion by 2035, growing at a CAGR of 4.12% over the next decade. The rising prevalence of respirat...
April 21, 2026
Based on market forecasts, the global gene vector market, projected at USD 9.61 billion in 2025, is expected to reach USD 64.38 billion by 2035, growing at a CAGR of 21% over the forecast period. The gene vector market is growing due to rising demand...
April 21, 2026
According to forecasts, the global kidney organ-on-a-chip market will grow from USD 192 million in 2024 to USD 1314.52 million by 2034, with an expected CAGR of 21.27%. A rise in CKD cases and advances in materials are fueling the global market. Nort...
April 21, 2026
Projections indicate that, cell and gene therapy CRO industry is projected to rise from USD 4.90 billion in 2024 to USD 12.59 billion by 2034, reflecting a CAGR of 9.9% over the next decade. The cell and gene therapy CRO market is growing as CROs wor...
January 07, 2026
Based on market forecasts, the chemical/gas sterilizers market was valued at USD 1.55 billion in 2025, reached USD 1.62 billion in 2026, and is projected to grow to USD 2.47 billion by 2035, registering a CAGR of 4.76% from 2026 to 2035.The chemical/...
April 21, 2026
According to market projections, the pharmaceutical CDMO sector is expected to grow from USD 167.96 billion in 2025 to USD 337.89 billion by 2035, reflecting a CAGR of 7.24%. Pharma companies face challenges in researching and manufacturing new thera...
April 20, 2026
Projections indicate that, APAC cell and gene therapy industry is projected to rise from USD 1.78 billion in 2025 to USD 11.74 billion by 2035, reflecting a CAGR of 20.7% over the next decade. A surge in wider demand for advanced therapies due to ris...
April 21, 2026
The digital health automation market is growing as it improves healthcare access and equity by providing remote care. It also grows productivity, streamlines scheduling streamlining appointment, and increases compliance with health care regulations. ...
April 21, 2026
According to market projections, the CRISPR technology sector is expected to grow from USD 5.72 billion in 2024 to USD 26.22 billion by 2034, reflecting a CAGR of 16.54%. In 2024, North America led the global CRISPR technology market, while Asia-Paci...
January 19, 2026
According to market projections, the generic pharmaceuticals sector is expected to grow from USD 460.47 billion in 2025 to USD 1026.8 billion by 2035, reflecting a CAGR of 8.35%. The rise in patent expiration, increasing demand for cost-effective and...
April 21, 2026
The biopharmaceuticals market size is calculated at $ 474.28 bn in 2025 is to hit $1540.14 bn by 2035. The biopharmaceuticals market is growing rapidly, driven by advances in biologics, personalized medicine, and gene therapy. Innovations in monoclon...
January 16, 2026
According to our projections, the inhaler solution market is experiencing steady expansion, supported by rising asthma and COPD prevalence, with revenues expected to reach USD 56 billion by 2035 from USD 33.32 billion in 2026 estimating growth at a 5...
January 12, 2026
According to market projections, the huntington's disease treatment sector is expected to grow from USD 716.76 million in 2025 to USD 1519.02 million by 2035, reflecting a CAGR of 7.8%. Huntington's disease treatment focuses on managing symptoms, as ...
January 09, 2026
According to our research, the mental health medications market was valued at USD 24.25 billion in 2025 and is projected to grow from USD 25.76 billion in 2026 to USD 44.26 billion by 2035, registering a CAGR of 6.2% during 2026 to 2035....
April 21, 2026
According to forecasts, the global AI in biopharmaceuticals market will grow from USD 1.55 billion in 2024 to USD 24.49 billion by 2034, with an expected CAGR of 32.27%. The implementation of artificial intelligence in biotechnology and pharmaceutica...
March 05, 2026
Projections indicate that, the global rapid microbial testing market will increase from USD 5.78 billion in 2025 to USD 15.04 billion by 2035, experiencing a CAGR of 10.04% over the next 10 years. The market is growing due to increasing infectious di...
April 21, 2026
Projections indicate that, AI in medical devices industry is projected to rise from USD 22.29 billion in 2024 to USD 886.39 billion by 2034, reflecting a CAGR of 44.53% over the next decade. The global focus on data analytics is fueling the wider ado...
April 21, 2026
Based on market forecasts, the U.S. osteoarthritis therapeutics market, projected at USD 3.27 billion in 2024, is expected to reach USD 6.46 billion by 2034, growing at a CAGR of 7.14% over the forecast period. The severe disease burden, the limited ...
March 11, 2026
Market insights predict, the North America in-vitro diagnostics industry is expected to grow from USD 54.09 billion in 2025 to USD 90.05 billion by 2035, driven by a CAGR of 5.23%. In 2024, reagents led North America's in-vitro diagnostics market. Se...
February 24, 2026
Based on our forecasts, the antidiabetics market was valued at USD 101.25 billion in 2025 and is projected to reach USD 112.18 billion in 2026, further expanding to USD 282.1 billion by 2035, registering a strong CAGR of 10.79% from 2026 to 2035....
April 21, 2026
According to market projections, small molecule inhibitor market was valued at USD 310.38 billion in 2025 and is expected to reach USD 328.22 billion by 2026, further expanding to around USD 542.87 billion by 2035, growing at a CAGR of 5.75% from 202...
April 21, 2026
Projections indicate that, biological therapies industry is projected to rise from USD 458.47 billion in 2024 to USD 1107.66 billion by 2034, reflecting a CAGR of 9.35% over the next decade. The biological therapies market is rising due to the rising...
February 24, 2026
Market insights predict the global antibody drug conjugate (ADC) industry will increase from USD 13.51 billion in 2025 to USD 32.66 billion by 2035, achieving a CAGR of 9.23%. The rising number of cancer cases and the rising need for safe, efficient ...
April 21, 2026
According to market projections, the cardiometabolic diseases market was valued at USD 292.04 billion in 2026 and is projected to reach approximately USD 1,987.69 billion by 2035, growing at a strong CAGR of 23.75% from 2026 to 2035. The cardiometabo...
April 21, 2026
Market insights predict, the branded generics industry is expected to grow from USD 383.1 billion in 2025 to USD 867.21 billion by 2035, driven by a CAGR of 8.47%. The branded generics market is growing due to the rising prevalence of chronic health ...
January 16, 2026
Our projections indicate, the U.S. Cell and Gene Therapy CDMO market is experiencing exponential growth driven by expanding clinical pipelines and increasing outsourcing of complex biologics manufacturing. With revenues projected to rise from USD 4.0...
April 21, 2026
The next-generation metabolic therapies market is witnessing strong expansion and is expected to generate revenue in the hundreds of millions during the forecast period from 2026 to 2035, driven by rising cases of metabolic disorders such as obesity,...
April 21, 2026
According to forecasts, the global alopecia areata market will grow from USD 3.32 billion in 2024 to USD 6.92 billion by 2034, with an expected CAGR of 7.6%. AI is transforming the Alopecia Areata market by improving diagnosis, treatment, and researc...
April 21, 2026
Market insights predict the global drug reference apps industry will increase from USD 1.47 billion in 2025 to USD 3.55 billion by 2035, achieving a CAGR of 9.20%. The drug reference apps market is growing due to digital transformation. North America...
April 21, 2026
The behavioral mental health market is expanding due to growing digital platforms as well as increasing use of ketamine therapies. North America led the market due to the presence of a strong healthcare sector....
April 21, 2026
Market insights predict, the virtual biopsy market industry is expected to grow from USD 0.77 billion in 2024 to USD 2.96 billion by 2034, driven by a CAGR of 14.5%. The market is growing due to rising demand for non-invasive diagnostic techniques an...
April 21, 2026
Market insights predict, the gRNA industry is expected to grow from USD 592.66 million in 2024 to USD 3,296.45 million by 2034, driven by a CAGR of 18.72%. Growing research in genomics due to rare diseases and gene and cell therapy drives the use of ...
March 11, 2026
Based on our market forecasts, the patient lift market was valued at USD 2.15 billion in 2025 and is projected to reach USD 2.24 billion in 2026, eventually expanding to around USD 3.29 billion by 2035, growing at a CAGR of 4.35% during 2026–20...
April 21, 2026
The AI-based pharmaceutical R&D services market is growing due to rising demand for automation. North America’s dominance can be attributed to the rising R&D in developing novel therapeutics....
April 21, 2026
Market insights predict the global chatbots for mental health and therapy industry will increase USD 12.21 billion by 2035, achieving a healthy CAGR of 21.3%, driven by the need for accessible care. These bots offer 24/7 support, thanks to advancemen...
April 21, 2026
The global market is stepping into streamlining laboratory workflows is fueling its global expansion. North America dominated the market due to the higher adoption of RCM platforms and a strong regulatory landscape....
April 21, 2026
According to market projections, the hemophilia sector is expected to grow from USD 14.34 billion in 2024 to USD 27.27 billion by 2034, reflecting a CAGR of 6.64%. Hemophilia affects over 1.1M globally, often undiagnosed. Advances like gene therapy a...
April 21, 2026
According to forecasts, the global antipsychotic drugs market will grow from USD 19.45 billion in 2024 to USD 41.21 billion by 2034, with an expected CAGR of 7.8%. Antipsychotic drugs help manage symptoms of mental health conditions like schizophreni...
January 21, 2026
According to our projections, the global cellulose esters and ethers market was valued at USD 7.05 billion in 2025 and reached USD 7.42 billion in 2026, with projections indicating growth to approximately USD 11.75 billion by 2035 at a CAGR of 5.24% ...
April 27, 2026
U.S. Bispecific Antibody Market (By Therapeutic Area/Indication: Oncology, Immuno-inflammation/Autoimmunity, Infectious Diseases, Ophthalmology/Rare Diseases/Others; By Format/Architecture: Dual-variable/IgG-based bispecifics, T-cell Engagers, Bispec...
April 09, 2026
Drugs Market ( By Product Type: Prescription Drugs Over-the-Counter (OTC) Drugs; By Therapeutic Area: Oncology, Cardiovascular, Central Nervous System, Respiratory, Infectious Diseases, Gastrointestinal, Diabetes, Autoimmune Disorders, Dermatology, O...
April 21, 2026
According to report estimations, the dental market size is calculated at USD 44.33 bn in 2025 is to hit USD 135.73 bn by 2035. The WHO's Global Oral Health Action Plan (2023-2030) aims to expand universal oral health coverage. In 2024, Dantech Digita...
April 21, 2026
Market insights predict, the human platelet lysate industry is expected to grow from USD 587 million in 2025 to USD 2416 million by 2035, driven by a CAGR of 15.19%. The human platelet lysate market is growing due to the rising usage in developing ce...
April 21, 2026
According to market projections, the gene therapies for cancer treatment sector is expected to grow from USD 8.28 billion in 2024 to USD 238.77 billion by 2034, reflecting a CAGR of 39.94%. The rising prevalence of cancer and the growing demand for p...
April 06, 2026
Lateral Flow Assays Market (By Product Type: Kits & Reagents, Readers/Analyzers, Ancillary/Consumables; By Technique: Sandwich Assays, Competitive Assays, Multiplex Detection; By Application: Infectious Disease Testing, Pregnancy & Fertility ...
January 29, 2026
According to forecasts, the global nanoparticle synthesis system market will grow from USD 0.78 billion in 2025 to USD 2.28 billion by 2035, with an expected CAGR of 11.34%. The nanoparticle synthesis system market is growing because nanoparticle syn...
April 24, 2026
Biosimilar Monoclonal Antibodies Market (By Type: Adalimumab, Bevacizumab, Infliximab, Rituximab, Trastuzumab, Others; By Indication: Oncology, Autoimmune diseases, Others; By End User: Hospitals, Cancer treatment centers, Others; By Region: North Am...
April 21, 2026
According to market projections, the digital mental health platforms sector is expected to grow from USD 0.80 billion in 2024 to USD 2.49 billion by 2034, reflecting a CAGR of 12.37%. The global market is driven by the accelerating advancements and b...
March 09, 2026
Based on our market research, the antimicrobial wound cleanser market was valued at USD 560.21 million in 2025 and is estimated to reach USD 585.42 million in 2026, eventually expanding to USD 869.99 million by 2035, growing at a CAGR of 4.5% during ...
April 21, 2026
According to forecasts, the global myasthenia gravis treatment market will grow from USD 1.55 billion in 2024 to USD 3.29 billion by 2034, with an expected CAGR of 7.84%. The myasthenia gravis treatment market is growing due to the rising prevalence ...
April 21, 2026
The exosome cell and gene therapy market is booming, driven by its use in treating cancer, rare, and genetic diseases. With tech like AI and automation, personalized therapies are improving care. North America leads, while Asia Pacific sees rapid gro...
February 04, 2026
According to forecasts, the global active pharmaceutical ingredients market will grow from USD 219.7 billion in 2025 to USD 418.64 billion by 2035, with an expected CAGR of 6.66%. In 2022, North America led the global active pharmaceutical ingredient...
April 21, 2026
According to market projections, the diabetic ketoacidosis treatment sector is expected to grow from USD 930.89 million in 2025 to USD 1426.15 million by 2035, reflecting a CAGR of 4.36%. The diabetic ketoacidosis treatment market due to rising...
April 21, 2026
Market insights predict the global bipolar disorder treatment industry will increase from USD 9.24 billion in 2024 to USD 15.67 billion by 2034, achieving a CAGR of 5.43%. In 2024, North America led the bipolar disorder treatment market, while Asia-P...
February 25, 2026
Based on our forecasts, the AI training dataset in healthcare market was valued at USD 520.1 million in 2025 and reached USD 639.41 million in 2026, and it is projected to grow significantly to USD 4,102.2 million by 2035, expanding at a strong CAGR ...
April 21, 2026
According to market projections, the U.S. clinical trials sector is expected to grow from USD 43.45 billion in 2025 to USD 80.42 billion by 2035, reflecting a CAGR of 6.35%. The U.S. clinical trials market is growing due to rising government investme...
April 20, 2026
According to forecasts, the North America cell and gene therapy market will grow from USD 4.46 billion in 2025 to USD 21.7 billion by 2035, with an expected CAGR of 17.1%. The North America cell and gene therapy market is growing due to the rising de...
January 20, 2026
Based on market forecasts, the personalized medicine sector will expand from USD 620.14 billion in 2025 to USD 1368.89 billion by 2035, experiencing a CAGR of 8.24%. The ever-increasing personalized medicine market, due to personalized medicine, aims...
April 02, 2026
Valves in Pharmaceutical Market (By Valve Type: Diaphragm Valves, Ball Valves, Butterfly Valves, Control Valves, Check & Safety Valves, Others; By Material: Stainless Steel, Alloys, Polymers & Plastics, Other Materials; By Application: Tradit...
April 21, 2026
Projections indicate that, AI in pharmaceuticals industry is projected to rise from USD 1.97 billion in 2025 to USD 21.51 billion by 2035, reflecting a CAGR of 27.01% over the next decade. The AI in the pharmaceutical market is growing as demand for ...
April 21, 2026
According to market projections, the antimalarial drugs sector is expected to grow from USD 1.07 billion in 2024 to USD 1.67 billion by 2034, reflecting a CAGR of 4.57%. Establishing awareness and government programs are propelling the global market ...
April 21, 2026
According to market projections, the bioconjugation sector is expected to grow from USD 5.52 billion in 2024 to USD 23.18 billion by 2034, reflecting a CAGR of 15.46%. Bioconjugation is playing a vital role in next-generation diagnostic tools such as...
March 18, 2026
Our projections indicate that, the pharmaceutical microbiology QC testing market report provides a comprehensive analysis of global industry trends, covering market size estimated at USD 4.6 billion in 2026 and projected to reach USD 13.84 billion by...
March 25, 2026
U.S. CAR T-Cell Therapies Market (By Drug Type: Axicabtagene Ciloleucel, Tisagenlecleucel, Brexucabtagene Autoleucel, Others; By Indication: Lymphoma, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), Others; By E...
April 21, 2026
The advanced therapies in biopharmaceutical medicine market is expanding due to increasing diseases as well as growing gene editing therapies. North America led the market due to the presence of a well-developed healthcare sector....
April 21, 2026
According to market projections, the global pulmonary arterial hypertension drugs market, valued at USD 8.04 billion in 2024, is anticipated to reach USD 12.38 billion by 2034, growing at a CAGR of 4.44% over the next decade. The market is growing du...
April 17, 2026
Hyper-Personalized Medicine Market (By Product: Diagnostics, Therapeutics, Medical Care, Nutrition & Wellness; By Technology: Genomics, Proteomics, Bioinformatics, Metabolomics, Artificial Intelligence (AI); By Application: Oncology, Cardiology, ...
April 14, 2026
Digital Health Monitoring Devices Market (By Device Type: Wearable devices, Non-wearable/home monitoring devices, Implantable & insertable monitoring devices, Clinical / hospital monitoring devices, Others; By Monitoring Parameter / Biomarker: Ca...
April 21, 2026
According to forecasts, the global Cell-Based Immunotherapies market will grow from USD 4.59 billion in 2024 to USD 18.62 billion by 2034, with an expected CAGR of 15.02%. The cell-based immunotherapies market is growing due to rising cancer incidenc...
April 21, 2026
Market insights predict, the rapid medical diagnostic kits industry is expected to grow from USD 28.12 billion in 2025 to USD 67 billion by 2035, driven by a CAGR of 9.07%. In 2024, North America led the rapid medical diagnostic kits market with a 37...
April 30, 2026
Biosimilar Antibodies Market (By Molecular Type: Monoclonal Antibodies (mAbs), Fusion Proteins; By Application: Oncology, Autoimmune Diseases, Others; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies; By Region: Nort...
April 21, 2026
Market insights predict the global in vitro release testing (IVRT) industry will increase from USD 65.55 million in 2024 to USD 252.64 million by 2034, achieving a CAGR of 14.47%.The market is growing due to rising demand for bioequivalent testing ...
April 21, 2026
Market insights predict the global life science plastic bottles industry will increase from USD 6.54 billion in 2024 to USD 11.97 billion by 2034, achieving a CAGR of 6.24%. The growing research and development activities and the growing demand for s...
April 21, 2026
According to market projections, the global U.S. healthcare IT market, valued at USD 160.52 billion in 2024, is anticipated to reach USD 566.48 billion by 2034, growing at a CAGR of 13.44% over the next decade. The implementation of regulator...
March 13, 2026
Market insights predict, the medical device contract manufacturing industry is expected to grow from USD 87.15 billion in 2025 to USD 244.34 billion by 2035, driven by a CAGR of 10.86%. The growing demand for medical devices and stringent regulatory ...
April 21, 2026
Projections indicate that, the global protein expression technology market will increase from USD 2.85 billion in 2024 to USD 5.58 billion by 2034, experiencing a CAGR of 6.94% over the next 10 years. The protein expression technology market is expan...
April 21, 2026
Market insights predict the global liquid biopsy IVD industry will increase from USD 2.21 billion in 2024 to USD 8.72 billion by 2034, achieving a CAGR of 14.79%. The liquid biopsy IBD market is growing due to the rising cases of cancer. North Amer...
April 21, 2026
According to forecasts, the global autologous cell therapy market will grow from USD 9.6 billion in 2024 to USD 54.21 billion by 2034, with an expected CAGR of 18.9%. The autologous cell therapy market is growing due to increasing demand for person...
April 21, 2026
Market insights predict the global biotechnology industry will increase to USD 5666.02 billion by 2035 rapidly fueled by breakthroughs in healthcare, agriculture, and industry. With a 12.5% CAGR over the next decade, innovations in gene therapy, CRIS...
April 21, 2026
According to market projections, the DNA vaccine sector is expected to grow from USD 553.89 million in 2024 to USD 1041.68 million by 2034, reflecting a CAGR of 6.52%. In 2024, North America led the global DNA vaccine market, with Asia-Pacific expect...
April 21, 2026
Due to the increasing burden of diverse cancer cases and demand for advanced chemotherapy drugs and services, the global market is expanding. The presence of advanced healthcare infrastructure and the growing demand for customized cancer care are d...
April 21, 2026
Market insights predict the global cellular reprogramming tools industry will increase from USD 456.1 million in 2024 to USD 760.1 million by 2034, achieving a CAGR of 5.24%. The market is growing due to rising demand for regenerative medicine and pe...
April 21, 2026
According to market projections, the radiation-induced dermatitis drug sector is expected to grow from USD 510 million in 2024 to USD 729.2 million by 2034, reflecting a CAGR of 3.64%. The growing need for radiation therapy and the increasing develop...
April 21, 2026
Based on market forecasts, the autologous stem cell & non-stem cell therapies sector will expand from USD 5.15 billion in 2024 to USD 82.32 billion by 2034, experiencing a CAGR of 32.26%. The autologous stem cell & non-stem cell therapies m...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com